Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Adherence news

Show

From To
Four day a week ART: sub-optimal drug levels but few virological failures

A poster at IAS 2016 reported on the effectiveness of a strategy in France to use reduced dose maintenance therapy. This involved only taking ART for four rather than seven days a week.

Published
20 September 2016
From
HIV i-Base
Reducing clinic visits can support retention in HIV care, African studies show

Interventions which reduce the need for people to attend clinics are proving highly successful in retaining people in care and supporting adherence to HIV medication in southern

Published
26 July 2016
By
Keith Alcorn
Smartphone app could help high-risk HIV men stay on their meds

Dworkin created the app by gathering African-American HIV-infected men who have sex with men in focus groups and discussing the common treatment questions they wanted answers to and the appropriate language the app should use in responding.

Published
21 July 2016
From
Science Magazine
Sub-type C infection does not increase the risk of virologic failure when people are taking tenofovir-containing first-line ART

There is no evidence that HIV-positive people with sub-type C infection have an increased risk of treatment failure when receiving tenofovir-containing regimens, investigators from the UK report in

Published
08 June 2016
By
Michael Carter
In Option B+, side-effects and needing time to think are key reasons for not taking HIV medication

A qualitative study of women in Malawi who chose not to take HIV treatment as part of the country’s Option B+ programme, or who interrupted their treatment,

Published
19 May 2016
By
Roger Pebody
Multiple social and health factors associated with irregular attendance at London HIV clinics

People who miss appointments for HIV care are more likely to have money problems, childcare responsibilities and a history of depression according to a recent UK study. While

Published
22 April 2016
By
Roger Pebody
People who use drugs still adherent to PrEP

New research conducted with a group of PrEP clients at the San Francisco AIDS Foundation PrEP clinic suggests that people who use substances adhere to PrEP and stay in care at about the same rate as people who do not use drugs.

Published
13 April 2016
From
BETA blog
People not taking HIV treatment feel under pressure to ‘do the right thing’

Australian people living with HIV who have chosen not to take antiretrovirals and who have doubts about HIV medicine report feeling excluded and silenced within HIV organisations

Published
13 April 2016
By
Roger Pebody
More people with HIV are achieving viral suppression in US, but about 40% remain above transmission thresholds

A growing proportion of people with HIV are reaching an undetectable viral load on antiretroviral therapy (ART), according to a pair of studies from the US Centers

Published
07 April 2016
By
Liz Highleyman
African women in London with poor adherence feel that HIV treatment is difficult and unrelenting

A qualitative study with West African women living in London who have difficulties adhering to their HIV treatment has found that many think of HIV treatment as

Published
04 April 2016
By
Roger Pebody
← First12345...36Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close